The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Clark William D since year 2005.
The trader's CIK number is 1355415.
At the time of this reporting, Clark William D is the Sr. VP, Chief Business Officer of Vanda Pharmaceuticals Inc. .
(stock ticker symbol VNDA).
See this page for all insider trading activities at Vanda Pharmaceuticals Inc. .
Stock purchases, sales, and option exercises reported by insider Clark William D since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-08-07
VNDA
Vanda Pharmaceuticals Inc.
Purchase
50,000
.99
49,500
2007-10-01
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
3,200
.33
1,059
2007-10-01
VNDA
Vanda Pharmaceuticals Inc.
Sale
3,200
13.87
44,384
2007-08-01
VNDA
Vanda Pharmaceuticals Inc.
Sale
3,200
18.84
60,288
2007-08-01
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
3,200
.33
1,059
2007-06-01
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
3,200
.33
1,059
2007-06-01
VNDA
Vanda Pharmaceuticals Inc.
Sale
3,200
20.13
64,409
2007-04-02
VNDA
Vanda Pharmaceuticals Inc.
Sale
3,200
24.13
77,216
2007-04-02
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
3,200
.33
1,059
2007-02-01
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
3,200
.33
1,056
2007-02-01
VNDA
Vanda Pharmaceuticals Inc.
Sale
3,200
29.56
94,587
2006-12-11
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
15,000
.33
4,950
2006-12-11
VNDA
Vanda Pharmaceuticals Inc.
Sale
15,000
26.28
394,165
2006-11-07
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
400
.33
132
2006-11-08
VNDA
Vanda Pharmaceuticals Inc.
Option Exercise
18,600
.33
6,138
2006-11-07
VNDA
Vanda Pharmaceuticals Inc.
Sale
400
11.56
4,622
2006-11-08
VNDA
Vanda Pharmaceuticals Inc.
Sale
12,300
11.19
137,608
2006-11-08
VNDA
Vanda Pharmaceuticals Inc.
Sale
6,300
11.57
72,891
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Clark William D
(Sr. VP, Chief Business Officer of Vanda Pharmaceuticals Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
